Top compounds associated with response to TSFM


Feature Type Standardized
Nominal ANOVA
mRNA birinapant CTRPv2 pan-cancer AAC -0.1 0.007
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.007
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.083 0.008
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.086 0.009
mRNA MP470 GDSC1000 pan-cancer AAC 0.084 0.01
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.085 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.084 0.01
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.083 0.01
Download CSV